PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC
Visit https://www.peervoice.com/HGH860 to view the entire programme with slides. After completing “Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC”, participants will be able to: Apply current evidence-based treatment guidelines in patients with molecular biomarker–positive non–small-cell lung cancer (NSCLC); Propose personalised treatment plans for patients with molecular biomarker–positive NSCLC; and Identify key clinical challenges encountered in the treatment of NSCLC, including next steps in patients without targetable driver mutations.